Back to mobile site

Exact Sciences (EXAS) Tops Q3 EPS by 7c; Guides Above Views

October 30, 2017 4:09 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $65.02 million.

GUIDANCE:

Exact Sciences sees FY2017 revenue of $254-257 million, versus the consensus of $244.25 million.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings